Suppr超能文献

去泛素化酶调节由PARK2介导的线粒体自噬。

Deubiquitinating enzymes regulate PARK2-mediated mitophagy.

作者信息

Wang Yuqing, Serricchio Mauro, Jauregui Miluska, Shanbhag Riya, Stoltz Tasha, Di Paolo Caitlin T, Kim Peter K, McQuibban G Angus

机构信息

a Cell Biology Program ; The Hospital for Sick Children ; Toronto , ON Canada.

出版信息

Autophagy. 2015 Apr 3;11(4):595-606. doi: 10.1080/15548627.2015.1034408.

Abstract

The selective degradation of mitochondria by the process of autophagy, termed mitophagy, is one of the major mechanisms of mitochondrial quality control. The best-studied mitophagy pathway is the one mediated by PINK1 and PARK2/Parkin. From recent studies it has become clear that ubiquitin-ligation plays a pivotal role and most of the focus has been on the role of ubiquitination of mitochondrial proteins in mitophagy. Even though ubiquitination is a reversible process, very little is known about the role of deubiquitinating enzymes (DUBs) in mitophagy. Here, we report that 2 mitochondrial DUBs, USP30 and USP35, regulate PARK2-mediated mitophagy. We show that USP30 and USP35 can delay PARK2-mediated mitophagy using a quantitative mitophagy assay. Furthermore, we show that USP30 delays mitophagy by delaying PARK2 recruitment to the mitochondria during mitophagy. USP35 does not delay PARK2 recruitment, suggesting that it regulates mitophagy through an alternative mechanism. Interestingly, USP35 only associates with polarized mitochondria, and rapidly translocates to the cytosol during CCCP-induced mitophagy. It is clear that PARK2-mediated mitophagy is regulated at many steps in this important quality control pathway. Taken together, these findings demonstrate an important role of mitochondrial-associated DUBs in mitophagy. Because defects in mitochondria quality control are implicated in many neurodegenerative disorders, our study provides clear rationales for the design and development of drugs for the therapeutic treatment of neurodegenerative diseases such as Parkinson and Alzheimer diseases.

摘要

通过自噬过程选择性降解线粒体,即线粒体自噬,是线粒体质量控制的主要机制之一。研究最深入的线粒体自噬途径是由PINK1和PARK2/帕金介导的途径。从最近的研究中可以清楚地看出,泛素连接起着关键作用,并且大部分研究重点都集中在线粒体蛋白泛素化在线粒体自噬中的作用。尽管泛素化是一个可逆过程,但关于去泛素化酶(DUBs)在线粒体自噬中的作用却知之甚少。在这里,我们报告2种线粒体DUBs,USP30和USP35,调节PARK2介导的线粒体自噬。我们使用定量线粒体自噬测定法表明,USP30和USP35可以延迟PARK2介导的线粒体自噬。此外,我们表明USP30通过在自噬过程中延迟PARK2募集到线粒体来延迟自噬。USP35不会延迟PARK2募集,这表明它通过另一种机制调节自噬。有趣的是,USP35仅与极化线粒体相关联,并在CCCP诱导的自噬过程中迅速转运到细胞质中。很明显,PARK2介导的线粒体自噬在这个重要的质量控制途径的许多步骤中受到调节。综上所述,这些发现证明了线粒体相关DUBs在线粒体自噬中的重要作用。由于线粒体质量控制缺陷与许多神经退行性疾病有关,我们的研究为设计和开发用于治疗帕金森病和阿尔茨海默病等神经退行性疾病的药物提供了明确的理论依据。

相似文献

5
USP8 and PARK2/parkin-mediated mitophagy.USP8与PARK2/帕金蛋白介导的线粒体自噬
Autophagy. 2015;11(2):428-9. doi: 10.1080/15548627.2015.1009794.
8
Phospho-ubiquitin-PARK2 complex as a marker for mitophagy defects.磷酸泛素-PARK2 复合物作为自噬缺陷的标志物。
Autophagy. 2017 Jan 2;13(1):201-211. doi: 10.1080/15548627.2016.1254852. Epub 2016 Nov 15.
9
Mechanisms of mitophagy: PINK1, Parkin, USP30 and beyond.线粒体自噬的机制:PINK1、帕金蛋白、USP30及其他相关蛋白
Free Radic Biol Med. 2016 Nov;100:210-222. doi: 10.1016/j.freeradbiomed.2016.04.015. Epub 2016 Apr 16.

引用本文的文献

1
Mitochondrial Metabolism in T-Cell Exhaustion.T细胞耗竭中的线粒体代谢
Int J Mol Sci. 2025 Jul 31;26(15):7400. doi: 10.3390/ijms26157400.
3
AKT and DUBs: a bidirectional relationship.AKT与去泛素化酶:一种双向关系。
Cell Mol Biol Lett. 2025 Jul 7;30(1):77. doi: 10.1186/s11658-025-00753-3.

本文引用的文献

7
Regulation of proteolysis by human deubiquitinating enzymes.人去泛素化酶对蛋白质水解的调控
Biochim Biophys Acta. 2014 Jan;1843(1):114-28. doi: 10.1016/j.bbamcr.2013.06.027. Epub 2013 Jul 9.
10
NBR1 acts as an autophagy receptor for peroxisomes.NBR1 作为过氧化物酶体的自噬受体发挥作用。
J Cell Sci. 2013 Feb 15;126(Pt 4):939-52. doi: 10.1242/jcs.114819. Epub 2012 Dec 13.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验